...
首页> 外文期刊>Clinical rheumatology >Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome.
【24h】

Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome.

机译:纤维肌痛和头痛:一项流行病学研究,支持偏头痛是纤维肌痛综合征的一部分。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fibromyalgia is defined by widespread body pain, tenderness to palpation of tender point areas, and constitutional symptoms. The literature reports headache in about half of fibromyalgia patients. The current epidemiological study was designed to determine the prevalence and characteristics of headache in fibromyalgia patients. Treatment-seeking fibromyalgia patients were evaluated with measures for fibromyalgia, chronic headache, quality of life, and psychological distress. Multivariate analysis of variance (MANOVA) and t-tests were used to identify significant differences, as appropriate. A total of 100 fibromyalgia patients were screened (24 fibromyalgia without headache and 76 fibromyalgia with headache). International Headache Society diagnoses included: migraine alone (n = 15 with aura, n = 17 without aura), tension-type alone (n = 18), combined migraine and tension-type (n = 16), post-traumatic (n = 4), and probable analgesic overuse headache (n = 6). Fibromyalgia tender point scores and counts and most measures of pain severity, sleep disruption, or psychological distress were not significantly different between fibromyalgia patients with and without headache. As expected, the fibromyalgia patients with headache scored higher on the Headache Impact Test (HIT-6) (62.1 +/- 0.9 vs 48.3 +/- 1.6, p < 0.001). HIT-6 scores were >60 in 80% of fibromyalgia plus headache patients, representing severe impact from headache, and 56-58 in 4%, representing substantial impact. In summary, chronic headache was endorsed by 76% of treatment-seeking fibromyalgia patients, with 84% reporting substantial or severe impact from their headaches. Migraine was diagnosed in 63% of fibromyalgia plus headache patients, with probable analgesic overuse headache in only 8%. General measures of pain, pain-related disability, sleep quality, and psychological distress were similar in fibromyalgia patients with and without headache. Therefore, fibromyalgia patients with headache do not appear to represent a significantly different subgroup compared to fibromyalgia patients without headache. The high prevalence and significant impact associated with chronic headache in fibromyalgia patients, however, warrants inclusion of a headache assessment as part of the routine evaluation of fibromyalgia patients.
机译:纤维肌痛的定义为广泛的身体疼痛,触及触痛点区域的触痛和体质症状。文献报道约有一半的纤维肌痛患者头痛。当前的流行病学研究旨在确定纤维肌痛患者头痛的患病率和特征。对寻求治疗的纤维肌痛患者进行了纤维肌痛,慢性头痛,生活质量和心理困扰的评估。酌情使用多变量方差分析(MANOVA)和t检验来识别显着差异。总共筛选了100例肌纤维痛患者(24例无头痛的纤维肌痛和76例头痛的纤维肌痛)。国际头痛学会的诊断包括:偏头痛单独(n = 15,有先兆,n = 17,没有先兆),单独紧张型(n = 18),偏头痛和紧张型联合(n = 16),创伤后(n = 4),并且可能是止痛药过度使用头痛(n = 6)。在有头痛和无头痛的纤维肌痛患者中,纤维肌痛的软化点得分和计数以及大多数疼痛程度,睡眠中断或心理困扰的测量指标均无显着差异。正如预期的那样,头痛的纤维肌痛患者在“头痛冲击测试”(HIT-6)上得分更高(62.1 +/- 0.9与48.3 +/- 1.6,p <0.001)。在80%的纤维肌痛加头痛患者中,HIT-6得分> 60,代表头痛的严重影响,在4%的HIT-6中得分为56-58,代表的是实质性影响。总之,寻求治疗的肌肌痛患者中有76%认可慢性头痛,其中84%的患者报告他们的头痛有严重或严重的影响。 63%的纤维肌痛加头痛患者被诊断为偏头痛,而止痛药过度使用头痛的诊断仅占8%。在有或没有头痛的纤维肌痛患者中,对疼痛,与疼痛相关的残疾,睡眠质量和心理困扰的一般指标相似。因此,与没有头痛的纤维肌痛患者相比,头痛的纤维肌痛患者似乎没有代表明显不同的亚组。然而,在纤维肌痛患者中与慢性头痛相关的高患病率和显着影响值得将头痛评估纳入纤维肌痛患者常规评估的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号